Efficacy of vaccination on Staphylococcus aureus and coagulase-negative staphylococci intramammary infection dynamics in 2 dairy herds

Journal of Dairy Science

Volumn 97, Issue 8, 2014, Pages 5250-5264

  Schukken, Y H ^a,b   Bronzo, V ^c   Locatelli, C ^c   Pollera, C ^c   Rota, N ^c   Casula, A ^c   Testa, F ^c   Scaccabarozzi, L ^c   March, R ^d   Zalduendo, D ^d   Guix, R ^d   Moroni, P ^a,c  

^a Department of Obstetrics Gynecology   (United States)

^b GD ANIMAL HEALTH   (Netherlands)

^c UNIVERSITY OF MILAN   (Italy)

^d LABORATORIOS HIPRA S A   (Spain)

Author keywords

Coagulase negative staphylococci; Intramammary infection; Staphylococcus aureus; Vaccine

Indexed keywords

BACTERIAL VACCINE; COAGULASE;

ANIMAL; BOVINE; FEMALE; IMMUNOLOGY; INCIDENCE; MASTITIS, BOVINE; METABOLISM; MICROBIOLOGY; PREVALENCE; SPAIN; STANDARDS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VACCINATION; VETERINARY;

ANIMALS; BACTERIAL VACCINES; CATTLE; COAGULASE; FEMALE; INCIDENCE; MASTITIS, BOVINE; PREVALENCE; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VACCINATION;

EID: 84904426991     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2014-8008     Document Type: Article

References (31)

1. Andersen S., Dohoo I.R., Olde Riekerink R., Stryhn H. Diagnosing intramammary infections: Evaluating expert opinions on the definition of intramammary infection using conjoint analysis. J. Dairy Sci. 2010, 93:2966-2975. Mastitis Research Workers' Conference.
2. Barkema H.W., Schukken Y.H., Zadoks R.N. Invited review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J. Dairy Sci. 2006, 89:1877-1895.
3. Barlow J.W., Zadoks R.N., Schukken Y.H. Effect of lactation therapy on Staphylococcus aureus transmission dynamics in two commercial dairy herds. BMC Vet. Res. 2013, 9:28-40.
4. Cha E., Bar D., Hertl J.A., Tauer L.W., Bennett G., González R.N., Schukken Y.H., Welcome F.L., Gröhn Y.T. The cost and management of different types of clinical mastitis in dairy cows estimated by dynamic programming. J. Dairy Sci. 2011, 94:4476-4487.
5. Daum R.S., Spellberg B. Progress toward a Staphylococcus aureus vaccine. Clin. Infect. Dis. 2012, 54:560-567.
6. Dohoo I.R. The design of randomized controlled trials of veterinary vaccines. Anim. Health Res. Rev. 2004, 5:235-238.
7. Dohoo I.R., Smith J., Andersen S., Kelton D.F., Godden S. Diagnosing intramammary infections: Evaluation of definitions based on a single milk sample. J. Dairy Sci. 2011, 94:250-261. Mastitis Research Workers' Conference.
8. Haber M., Longini I.M., Halloran M.E. Measures of the effects of vaccination in a randomly mixing population. Int. J. Epidemiol. 1991, 20:300-310.
9. Halasa T., Huijps K., Østerås O., Hogeveen H. Economic effects of bovine mastitis and mastitis management: A review. Vet. Q. 2007, 29:18-31.
10. Halloran M.E., Anderson R.M., Azevedo-Neto R.S., Bellini W.J., Branch O., Burke M.A., Compans R., Day K., Gooding L., Gupta S., Katz J., Kew O., Keyserling H., Krause R., Lal A.A., Massad E., McLean A.R., Rosa P., Rota P., Wiener P., Wynn S.G., Zanetta D.M. Population biology, evolution, and immunology of vaccination and vaccination programs. Am. J. Med. Sci. 1998, 315:76-86.
11. Halloran M.E., Ferguson N.M., Eubank S., Longini I.M., Cummings D.A., Lewis B., Xu S., Fraser C., Vullikanti A., Germann T.C., Wagener D., Beckman R., Kadau K., Barrett C., Macken C.A., Burke D.S., Cooley P. Modeling targeted layered containment of an influenza pandemic in the United States. Proc. Natl. Acad. Sci. USA 2008, 105:4639-4644.
12. Halloran M.E., Haber M., Longini I.M., Struchiner C.J. Direct and indirect effects in vaccine efficacy and effectiveness. Am. J. Epidemiol. 1991, 133:323-331.
13. Halloran M.E., Struchiner C.J., Longini I.M. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am. J. Epidemiol. 1997, 146:789-803.
14. Harro J.M., Peters B.M., O'May G.A., Archer N., Kerns P., Prabhakara R., Shirtliff M.E. Vaccine development in Staphylococcus aureus: Taking the biofilm phenotype into consideration. FEMS Immunol. Med. Microbiol. 2010, 59:306-323.
15. Hertl J.A., Schukken Y.H., Bar D., Bennett G.J., González R.N., Rauch B.J., Welcome F.L., Tauer L.W., Gröhn Y.T. The effect of recurrent episodes of clinical mastitis caused by gram-positive and gram-negative bacteria and other organisms on mortality and culling in Holstein dairy cows. J. Dairy Sci. 2011, 94:4863-4877.
16. ISO (International Organization for Standardization). 2007. Milking machine installations-Mechanical tests. Method 6690-2007. ISO, Geneva, Switzerland.
17. Lam T.J., DeJong M.C., Schukken Y.H., Brand A. Mathematical modeling to estimate efficacy of postmilking teat disinfection in split-udder trials of dairy cows. J. Dairy Sci. 1996, 79:62-70.
18. Lam T.J., van Vliet J.H., Schukken Y.H., Grommers F.J., van Velden-Russcher A., Barkema H.W., Brand A. The effect of discontinuation of postmilking teat disinfection in low somatic cell count herds. II. Dynamics of intramammary infections. Vet. Q. 1997, 19:47-53.
19. Lu Z., Grohn Y.T., Smith R.L., Wolfgang D.R., Van Kessel J.A., Schukken Y.H. Assessing the potential impact of Salmonella vaccines in an endemically infected dairy herd. J. Theor. Biol. 2009, 259:770-784.
20. Middleton J.R., Luby C.D., Adams D.S. Efficacy of vaccination against staphylococcal mastitis: A review and new data. Vet. Microbiol. 2009, 134:192-198.
21. Morant S.V., Dodd F.H., Natzke R.P. Consequences of diagnostic errors in mastitis therapy trials. J. Dairy Res. 1988, 55:315-329.
22. Laboratory Handbook on Bovine Mastitis 1999, NMC (National Mastitis Council), National Mastitis Council, Madison, WI.
23. Olde Riekerink R.G., Barkema H.W., Scholl D.T., Poole D.E., Kelton D.F. Management practices associated with the bulk-milk prevalence of Staphylococcus aureus in Canadian dairy farms. Prev. Vet. Med. 2010, 97:20-28.
24. Pereira U.P., Oliveira D.G., Mesquita L.R., Costa G.M., Pereira L.J. Efficacy of Staphylococcus aureus vaccines for bovine mastitis: A systematic review. Vet. Microbiol. 2011, 148:117-124.
25. Pérez M.M., Prenafeta A., Valle J., Penadés J., Rota C., Solano C., Marco J., Grilló M.J., Lasa I., Irache J.M., Maira-Litran T., Jiménez-Barbero J., Costa L., Pier G.B., de Andrés D., Amorena B. Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria. Vaccine 2009, 27:2379-2386.
26. Prenafeta A., March R., Foix A., Casals I., Costa L. Study of the humoral immunological response after vaccination with a Staphylococcus aureus biofilm-embedded bacterin in dairy cows: Possible role of the exopolysaccharide specific antibody production in the protection from Staphylococcus aureus induced mastitis. Vet. Immunol. Immunopathol. 2010, 134:208-217.
27. Reksen O., Gröhn Y.T., Barlow J.W., Schukken Y.H. Transmission dynamics of intramammary infections with coagulase-negative staphylococci. J. Dairy Sci. 2012, 95:4899-4910.
28. Schukken Y.H., Günther J., Fitzpatrick J., Fontaine M.C., Goetze L., Holst O., Leigh J., Petzl W., Schuberth H.J., Sipka A., Smith D.G., Quesnell R., Watts J., Yancey R., Zerbe H., Gurjar A., Zadoks R.N., Seyfert H.M. Host-response patterns of intramammary infections in dairy cows. Vet. Immunol. Immunopathol. 2011, 144:270-289. Members of the Pfizer Mastitis Research Consortium.
29. Smith T.H., Fox L.K., Middleton J.R. Outbreak of mastitis caused by one strain of Staphylococcus aureus in a closed dairy herd. J. Am. Vet. Med. Assoc. 1998, 212:553-556.
30. Torvaldsen S., McIntyre P.B. Observational methods in epidemiologic assessment of vaccine effectiveness. Commun. Dis. Intell. Q. Rep. 2002, 26:451-457.
31. Wilson D.J., Mallard B.A., Burton J.L., Schukken Y.H., Gröhn Y.T. Milk and serum J5-specific antibody responses, milk production change, and clinical effects following intramammary Escherichia coli challenge for J5 vaccinate and control cows. Clin. Vaccine Immunol. 2007, 14:693-699.